Author

Fathia Mami‐Chouaib

InsermORCID 0000-0001-9685-6011Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:statistical model· 2 Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1

Frequent Co-Authors

Aziza Caidi· 2 shared Alain GeyiD· 1 shared Arezki Guerda· 1 shared Camille DepenveilleriD· 1 shared Diane DamotteiD· 1 shared Elizabeth FabreiD· 1 shared Emilia Rabia· 1 shared Éric TartouriD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioinformatics

Aziza Caidi

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BioinformaticsJournal of Chemical Information and ModelingPeer-reviewedJun 26, 2026

PP-MAPS: dynamic pharmacophore signatures of protein-peptide interfaces from molecular dynamics trajectories

Camille Depenveiller, Arezki Guerda, Emilia Rabia…·Matthieu Montès

PP-MAPS extracts dynamic pharmacophore signatures from MD trajectories of protein-peptide complexes to analyze interactions and compare peptides and binding sites.

DOI 10.1021/acs.jcim.6c00605

protein structurestatistical model

𝕏 PostBluesky

ImmunologyJournal for ImmunoTherapy of CancerPeer-reviewedDec 1, 2024

Differential predictive value of resident memory CD8+T cell subpopulations in non-small-cell lung cancer patients treated by immunotherapy

Léa Paolini, Thi Tran, Stéphanie Corgnac…·Éric Tartour

The paper identifies two TRM subpopulations in NSCLC patients and shows that only DP TRM predicts response to PD-1 blockade immunotherapy.

29 citationstop 3%

humanbulk RNA-seq

𝕏 PostBluesky